Brii Biosciences Limited

As of December 31, 2025, BRII BIOSCIENCE LTD carries a market capitalization of 134.94M, placing it among publicly traded companies globally. Its enterprise value stands at -148.63M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

BRII BIOSCIENCE LTD's next confirmed earnings release is scheduled for March 19, 2027.

As of December 31, 2025, BRII BIOSCIENCE LTD has 720.56M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, BRII BIOSCIENCE LTD maintains a current ratio of 60.73, meaning it holds 60.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on August 5, 2026, BRII BIOSCIENCE LTD's stock has declined approximately 45.97% over the past 52 weeks.

As of December 31, 2025, BRII BIOSCIENCE LTD holds 277.37M in cash and equivalents against 1.28M in total debt, resulting in a net debt position of -86.78M. Total book value stands at 339.74M, with working capital of 276.04M providing operational flexibility.